Osteopontin induces β-catenin signaling through activation of Akt in prostate cancer cells

Experimental Cell Research

Volumn 316, Issue 1, 2010, Pages 1-11

  Robertson, Brian W ^a   Chellaiah, Meenakshi A ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

Akt; ILK; Osteopontin; PI3 kinase; TCF LEF; Catenin

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; HERMES ANTIGEN; INTEGRIN LINKED KINASE; LYMPHOID ENHANCING FACTOR; MATRILYSIN; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 70449701416     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.10.012     Document Type: Article

References (48)

1. Angelucci A., Festuccia C., Gravina G.L., Muzi P., Bonghi L., Vicentini C., and Bologna M. Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells. Prostate 59 (2004) 157-166
2. Cooper C.R., Chay C.H., and Pienta K.J. The role of alpha(v)beta(3) in prostate cancer progression. Neoplasia 4 (2002) 191-194
3. Thalmann G.N., Sikes R.A., Devoll R.E., Kiefer J.A., Markwalder R., Klima I., Farach-Carson C.M., Studer U.E., and Chung L.W. Osteopontin: possible role in prostate cancer progression. Clin. Cancer Res. 5 (1999) 2271-2277
4. Denhardt D.T., and Guo X. Osteopontin: a protein with diverse functions. FASEB J. 7 (1993) 1475-1482
5. Denhardt D.T., Giachelli C.M., and Rittling S.R. Role of osteopontin in cellular signaling and toxicant injury. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 723-749
6. Chellaiah M.A., and Hruska K.A. The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif. Tissue Int. 72 (2003) 197-205
7. Faccio R., Grano M., Colucci S., Zallone A.Z., Quaranta V., and Pelletier A.J. Activation of alphav beta3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin. Biochem. Biophys. Res. Commun. 249 (1998) 522-525
8. Zohar R., Suzuki N., Suzuki K., Arora P., Glogauer M., McCulloch C.A., and Sodek J. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J. Cell Physiol. 184 (2000) 118-130
9. Dedhar S., Argraves W.S., Suzuki S., Ruoslahti E., and Pierschbacher M.D. Human osteosarcoma cells resistant to detachment by an Arg-Gly-Asp-containing peptide overproduce the fibronectin receptor. J. Cell Biol. 105 (1987) 1175-1182
10. Dedhar S. Signal transduction via the beta 1 integrins is a required intermediate in interleukin-1 beta induction of alkaline phosphatase activity in human osteosarcoma cells. Exp. Cell Res. 183 (1989) 207-214
11. Sodek J., Ganss B., and McKee M.D. Osteopontin. Crit Rev. Oral Biol. Med. 11 (2000) 279-303
12. Weber G.F., Ashkar S., and Cantor H. Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proc. Assoc. Am. Physicians 109 (1997) 1-9
13. Hannigan G.E., Leung-Hagesteijn C., Fitz-Gibbon L., Coppolino M.G., Radeva G., Filmus J., Bell J.C., and Dedhar S. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379 (1996) 91-96
14. Qian Y., Zhong X., Flynn D.C., Zheng J.Z., Qiao M., Wu C., Dedhar S., Shi X., and Jiang B.H. ILK mediates actin filament rearrangements and cell migration and invasion through PI3K/Akt/Rac1 signaling. Oncogene 24 (2005) 3154-3165
15. Korah R., Boots M., and Wieder R. Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow. Cancer Res. 64 (2004) 4514-4522
16. Okamura M., Yamaji S., Nagashima Y., Nishikawa M., Yoshimoto N., Kido Y., Iemoto Y., Aoki I., and Ishigatsubo Y. Prognostic value of integrin beta1-ILK-pAkt signaling pathway in non-small cell lung cancer. Hum. Pathol. 38 (2007) 1081-1091
17. Nicholson K.M., and Anderson N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cell. Signal. 14 (2002) 381-395
18. Nicholson K.M., Streuli C.H., and Anderson N.G. Autocrine signalling through erbB receptors promotes constitutive activation of protein kinase B/Akt in breast cancer cell lines. Breast Cancer Res. Treat. 81 (2003) 117-128
19. Hanada M., Feng J., and Hemmings B.A. Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochim. Biophys. Acta 1697 (2004) 3-16
20. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., and Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995) 785-789
21. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., and He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108 (2002) 837-847
22. Liu S., Vinall R.L., Tepper C., Shi X.B., Xue L.R., Ma A.H., Wang L.Y., Fitzgerald L.D., Wu Z., Gandour-Edwards R., Vere White R.W., and Kung H.J. Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway. Oncogene 27 (2008) 499-505
23. Orsulic S., and Peifer M. An in vivo structure-function study of armadillo, the beta-catenin homologue, reveals both separate and overlapping regions of the protein required for cell adhesion and for wingless signaling. J. Cell Biol. 134 (1996) 1283-1300
24. Pai L.M., Kirkpatrick C., Blanton J., Oda H., Takeichi M., and Peifer M. Drosophila alpha-catenin and E-cadherin bind to distinct regions of Drosophila armadillo. J. Biol. Chem. 271 (1996) 32411-32420
25. Peifer M., and Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 287 (2000) 1606-1609
26. Hsu S.C., Galceran J., and Grosschedl R. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin. Mol. Cell. Biol. 18 (1998) 4807-4818
27. Huber O., Korn R., McLaughlin J., Ohsugi M., Herrmann B.G., and Kemler R. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech. Dev. 59 (1996) 3-10
28. Morin P.J., and Weeraratna A.T. Wnt signaling in human cancer. Cancer Treat. Res. 115 (2003) 169-187
29. Morin P.J. beta-Catenin signaling and cancer. BioEssays 21 (1999) 1021-1030
30. Desai B., Rogers M.J., and Chellaiah M.A. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Mol. Cancer 6 (2007) 18
31. Chellaiah M., Fitzgerald C., Filardo E.J., Cheresh D.A., and Hruska K.A. Osteopontin activation of c-src in human melanoma cells requires the cytoplasmic domain of the integrin alpha v-subunit. Endocrinology 137 (1996) 2432-2440
32. Nho R.S., Xia H., Kahm J., Kleidon J., Diebold D., and Henke C.A. Role of integrin-linked kinase in regulating phosphorylation of Akt and fibroblast survival in type I collagen matrices through a beta1 integrin viability signaling pathway. J. Biol. Chem. 28 (2005) 26630-26639
33. Carver D.J., Aman M.J., and Ravichandran K.S. SHIP inhibits Akt activation in B cells through regulation of Akt membrane localization. Blood 96 (2000) 1449-1456
34. Srivastava A.K., and Pandey S.K. Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol. Cell. Biochem. 182 (1998) 135-141
35. Ding V.W., Chen R.H., and McCormick F. Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J. Biol. Chem. 275 (2000) 32475-32481
36. Taurin S., Sandbo N., Qin Y., Browning D., and Dulin N.O. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. J. Biol. Chem. 281 (2006) 9971-9976
37. Carlinfante G., Vassiliou D., Svensson O., Wendel M., Heinegard D., and Andersson G. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma. Clin. Exp. Metastasis 20 (2003) 437-444
38. Mirza M., Shaughnessy E., Hurley J.K., Vanpatten K.A., Pestano G.A., He B., and Weber G.F. Osteopontin-c is a selective marker of breast cancer. Int. J. Cancer 122 (2008) 889-897
39. Caruso D.J., Carmack A.J., Lokeshwar V.B., Duncan R.C., Soloway M.S., and Lokeshwar B.L. Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence. Clin. Cancer Res. 14 (2008) 4111-4118
40. Woodgett J.R. Recent advances in the protein kinase B signaling pathway. Curr. Opin. Cell Biol. 17 (2005) 150-157
41. Mulholland D.J., Dedhar S., Wu H., and Nelson C.C. PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer. Oncogene 25 (2006) 329-337
42. McManus E.J., Sakamoto K., Armit L.J., Ronaldson L., Shpiro N., Marquez R., and Alessi D.R. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J. 24 8 (2005) 1571-1583
43. Rohde F., Rimkus C., Friederichs J., Rosenberg R., Marthen C., Doll D., Holzmann B., Siewert J.R., and Janssen K.P. Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer. Int. J. Cancer 121 (2007) 1717-1723
44. Kimelman D., and Xu W. beta-Catenin destruction complex: insights and questions from a structural perspective. Oncogene 25 (2006) 7482-7491
45. Katoh M., and Katoh M. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol. Ther. 5 (2006) 1059-1064
46. Fukumoto S., Hsieh C.M., Maemura K., Layne M.D., Yet S.F., Lee K.H., Matsui T., Rosenzweig A., Taylor W.G., Rubin J.S., Perrella M.A., and Lee M.E.S. Akt participation in the Wnt signaling pathway through Dishevelled. J. Biol. Chem. 276 (2001) 17479-17483
47. El-Tanani M.K., Campbell F.C., Kurisetty V., Jin D., McCann M., and Rudland P.S. The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev. 17 (2006) 463-474
48. Tuck A.B., Chambers A.F., and Allan A.L. Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management. J. Cell. Biochem. 102 (2007) 859-868